Octreotidă Rompharm (Octreotide)

Octreotide, the active ingredient in Octreotidă Rompharm, is a somatostatin analog presented as a sterile solution for subcutaneous injection use. It is employed in the management of hormone‑secreting tumors and certain gastrointestinal disorders in adult patients. GNH USA supplies Octreotidă Rompharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Octreotide is used across several endocrine‑related pathways, particularly controlling excessive hormone secretion. - Acromegaly: Reduces insulin‑like growth factor‑1 (IGF‑1) and growth hormone levels, helping control disease activity. - Carcinoid syndrome: Diminishes flushing and diarrhea — provides relief — and improves quality of life. - VIPoma/Medullary thyroid carcinoma: Controls  the  symptoms  of  excess  hormone  release  such  as  watery  diarr  and\n secret  of  serotonin  for  symptom  control  in  med  M  . - Prevent  for  post‑              .  

Octce